Utah Medical Products, Inc. (UTMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
UTMD Revenue Growth
UTMD Revenue Analysis (2014–2025)
As of May 8, 2026, Utah Medical Products, Inc. (UTMD) generated trailing twelve-month (TTM) revenue of $38.5 million, reflecting slight decline in growth of -1.2% year-over-year. The most recent quarter (Q4 2025) recorded $9.0 million in revenue, down 7.8% sequentially.
Looking at the longer-term picture, UTMD's 5-year compound annual growth rate (CAGR) stands at -1.8%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $52.3 million in 2022.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), MMSI (+11.2% YoY), and LMAT (+13.3% YoY), UTMD has underperformed the peer group in terms of revenue growth. Compare UTMD vs NVCR →
UTMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| UTMDCurrent | $39M | -1.2% | -1.8% | 29.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 LMAT | $250M | +13.3% | +14.0% | 27.2% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
UTMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $38.5M | -5.8% | $19.9M | 51.6% | $11.4M | 29.6% |
| 2024 | $40.9M | -18.6% | $24.1M | 59.0% | $13.6M | 33.2% |
| 2023 | $50.2M | -3.9% | $30.0M | 59.8% | $16.8M | 33.4% |
| 2022 | $52.3M | +6.6% | $32.2M | 61.6% | $19.8M | 37.9% |
| 2021 | $49.1M | +16.3% | $30.9M | 63.0% | $18.9M | 38.5% |
| 2020 | $42.2M | -10.1% | $25.5M | 60.6% | $13.7M | 32.5% |
| 2019 | $46.9M | +11.7% | $29.5M | 62.8% | $17.6M | 37.6% |
| 2018 | $42.0M | +1.4% | $26.3M | 62.6% | $18.7M | 44.5% |
| 2017 | $41.4M | +5.4% | $26.4M | 63.7% | $19.0M | 45.9% |
| 2016 | $39.3M | -2.1% | $23.7M | 60.3% | $16.2M | 41.2% |
See UTMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UTMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare UTMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonUTMD — Frequently Asked Questions
Quick answers to the most common questions about buying UTMD stock.
Is UTMD's revenue growth accelerating or slowing?
UTMD revenue growth slowed to -1.2%, below the 5-year CAGR of -1.8%. TTM revenue is $39M. The deceleration marks a shift from historical growth rates.
What is UTMD's long-term revenue growth rate?
Utah Medical Products, Inc.'s 5-year revenue CAGR of -1.8% reflects the variable expansion pattern. Current YoY growth of -1.2% is near this long-term average.
How is UTMD's revenue distributed by segment?
UTMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.